Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia-Reference-Cited by-同舟云学术

Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia

Published:2015-12 Issue:6 Volume:97 Page:848-854
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Niihori Tetsuya,Ouchi-Uchiyama Meri,Sasahara Yoji,Kaneko Takashi,Hashii Yoshiko,Irie Masahiro,Sato Atsushi,Saito-Nanjo Yuka,Funayama Ryo,Nagashima Takeshi,Inoue Shin-ichi,Nakayama Keiko,Ozono Keiichi,Kure Shigeo,Matsubara Yoichi,Imaizumi Masue,Aoki Yoko

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference32 articles.

1. Congenital thrombocytopenia and radio-ulnar synostosis: a new familial syndrome;Thompson;Br. J. Haematol.,2001

2. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation;Thompson;Nat. Genet.,2000

3. Proximal radio-ulnar synostosis with bone marrow failure syndrome in an infant without a HOXA11 mutation;Castillo-Caro;J. Pediatr. Hematol. Oncol.,2010

4. A case of amegakaryocytic thrombocytopenia with radio-ulnar synostosis syndrome, successfully treated with allogeneic bone marrow transplantation;Sugita;Haematologica,2007

5. A case of congenital bone marrow failure with radio-ulnar synostosis;Yoshida;Int. J. Hematol.,2010

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk assessment and genetic counseling for hematologic malignancies—Practice resource of the National Society of Genetic Counselors;Journal of Genetic Counseling;2024-08-27

2. A Unique Clinical Presentation of Congenital Thumb Aplasia, Radioulnar Synostosis, and Chiari Malformation: A Potential Pediatric Syndromic Association;Cureus;2024-08-06

3. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion;Blood Advances;2024-06-27

4. MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2;2024-06-25

5. MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2;2024-05-20